Skip to content
OpenCapital
Get started

Imax IMAX Financing Receivable Allowance For Credit Losses Nonaccrual Status

Other financials

Income statement

See full
Revenue$81.4M-6.1%
Gross profit$45.8M-13.9%
Operating income$10.0M-40.5%
Net income$4.2M+81.6%
EPS (diluted)$0.07+75.0%

Balance sheet

See full
Cash & equivalents$146.0M+50.4%
Total debt$11.1M-6.7%
Total equity$335.5M+12.0%
Total assets$893.2M+5.3%

Cash flow

See full
Operating cash flow$4.0M-42.0%
CapEx$2.1M+29.6%
Free cash flow$1.9M-64.2%

Valuation

See full
Market cap$2.47B+46.9%
P/E67.3×+0.2×
P/S6.1×+1.4×

Profitability

See full
Gross margin59%+4.4pp
Operating margin19.1%+5.6pp
Net margin9.1%+2.1pp
FCF margin28.5%+6.3pp

Returns & leverage

See full
Return on equity11.6%+2.6pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Imax in its filing.

Tagged under the XBRL concept imax:FinancingReceivableAllowanceForCreditLossesNonaccrualStatus.

The official record: Imax’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Imax's financing receivable allowance for credit losses nonaccrual status.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Imax's financing receivable allowance for credit losses nonaccrual status?
Imax (IMAX) reported financing receivable allowance for credit losses nonaccrual status of $9.35M in Q1 2026.
How has Imax's financing receivable allowance for credit losses nonaccrual status changed year-over-year?
Imax's financing receivable allowance for credit losses nonaccrual status increased by 4.3% year-over-year, from $8.97M to $9.35M.
What is the long-term trend for Imax's financing receivable allowance for credit losses nonaccrual status?
Over 2 years (2023 to 2025), Imax's financing receivable allowance for credit losses nonaccrual status has grown at a 2.0% compound annual growth rate (CAGR), from $8.88M to $9.24M.